Historical Investigation of the Creating Thought of Zuogui Pill（左归丸） and Yougui Pill（右归丸）

ZHOU Min; FANG Xiaoyang

doi:10.13288/j.11-2166/r.2015.11.001

您当前的位置：

首页 >

文章列表页 >

Historical Investigation of the Creating Thought of Zuogui Pill（左归丸） and Yougui Pill（右归丸）

更新时间：2021-11-17

- Historical Investigation of the Creating Thought of Zuogui Pill（左归丸） and Yougui Pill（右归丸）
- Journal of Traditional Chinese Medicine Vol. 56, Issue 11, Pages: 901-905(2015)
- 作者机构：
  
  中国科学院大学人文学院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2015.11.001
  CLC： R285.5
- Published：2015
- 稿件说明：
移动端阅览
[1]周敏,方晓阳.左归丸及右归丸创方思想的历史考察[J].中医杂志,2015,56(11):901-905.

ZHOU Min, FANG Xiaoyang. Historical Investigation of the Creating Thought of Zuogui Pill（左归丸） and Yougui Pill（右归丸）[J]. Journal of Traditional Chinese Medicine2015, 56(11): 901-905.
[1]周敏,方晓阳.左归丸及右归丸创方思想的历史考察[J].中医杂志,2015,56(11):901-905. DOI： 10.13288/j.11-2166/r.2015.11.001.

ZHOU Min, FANG Xiaoyang. Historical Investigation of the Creating Thought of Zuogui Pill（左归丸） and Yougui Pill（右归丸）[J]. Journal of Traditional Chinese Medicine2015, 56(11): 901-905. DOI： 10.13288/j.11-2166/r.2015.11.001.

摘要

左归丸、右归丸是张介宾治疗肾脏阴阳亏损的重方

既往对二方的组方讨论多局限于君、臣、佐、使的配伍理论、药物功效及统计分析

至于二方如何创制的问题着墨不多。认为从张介宾医学思想的传承以及对药物的认知方面分析

左归丸、右归丸其实是张介宾取"六味之意"

并依其真阴学说为核心

参以个人用药体悟而创制的新方。左归丸、右归丸在医方结构上具有同根的特点

用药之法也与《类经》和《景岳全书》中的记载相合

可视为张介宾将医理融于临证遣方的一种结果。

Abstract

Zuogui Pill and Yougui Pill are the important prescriptions of ZHANG Jiebin in treating Yin and Yang deficiency of kidney. Previously

the discussions about the composition of these two prescriptions were mainly limited in the compatibility theory of monarch

minister

assistant and guide

as well as prescription effect and statistical analysis. However

how these two prescriptions were created is seldom mentioned. Analysis from the medical thought inheritance of ZHANG Jiebin and the cognition of drugs shows that actually Zuogui Pill and Yougui Pill are the new created prescriptions of ZHANG Jiebin

he quoted the meaning of "six flavors"（六味）

and made his " true Yin"（真阴） theory as the core

combined with his individual medication knowledge and created them. Zuogui Pill and Yougui Pill share the same characteristics in the prescription structure

and the principles of drugs using are in consistency with "Lei Jing"（《类经》） and "Jingyue Quanshu"（《景岳全书》）. These can be regarded as the result of ZHANG Jiebin’s reconciliation of medical knowledge into clinical practice.

关键词

Keywords

references

查看原文

Views

773

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Impact of Zuogui Pill（左归丸）,Yougui Pill（右归丸） and Their Decomposed Recipes on the Expression of Renal Alkaline Phosphatase and Osteocalcin in Ovariectomized Osteoporosis Model Rats

Discussion on Prescription Characteristics of Zuogui Pill（左归丸） and Yougui Pill（右归丸） Based on the Theory “Herb Nature Belongs to Yang; flavor belongs to Yin”

Impact of Zuogui Pill（左归丸） and Yougui Pill（右归丸） on Expressions of PPARγ,C/EBPβ and C/EBPα Proteins in Femur Bone Marrow of Ovariectomized Rats

Data Mining of ZHANG Jiebin's Medication Rules in Syndrome Differentiation and Treatment of Severe Palpitations

Effect of Erzhi Tiangui Granules and Yougui Pill on Methylation Status of Snrpn and Peg1/Mest in Ovum of Mice with Kidney Deficiency

Related Author

LI Shujuan

SUN Yuejiao

REN Yanling

MENG Yue

QIN Zhen

REN Yanling

ZHANG Tianhao

AI Siyu

Related Institution

Liaoning University of Traditional Chinese Medicine

Liaoning University of Chinese Medicine

First Teaching Hospital of Tianjin University of Traditional Chinese Medicine， National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion

Graduate School， Tianjin University of Traditional Chinese Medicine

The Affiliated Hospital of Shandong University of Traditional Chinese Medicine

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰